Virginia Biotechnology Association

News!

Frederick Frank to Address Mid-Atlantic Bio Conference

Frederick Frank, one of the most significant dealmakers in the biotech and pharma industry’s history and current vice chairman of Peter J. Solomon Company, will address the 2010 Mid-Atlantic Bio Conference(Oct. 27-29), on October 28, at the North ... read more ».

Senator Mark Warner Hosts Export Opportunities Conference

Senator Mark Warner would like to invite members of the Virginia Biotechnology Association to a conference he is hosting focused on expanding export opportunities for Virginia businesses, on Monday, September 13 from 8:30 am to 1:30 pm.  The conference will feature a networking hour as well as ... read more ».

Take The Global Stage At 2011 BIO International Convention

Promote your expertise and define yourself as a biotech thought leader by contributing to the BIO Program as a session speaker or organizer at the 2011 BIO International Convention, Monday – Thursday, June 27 – 30, 2011 in Washington DC. The 2011 BIO International Convention Call for ... read more ».

6 Virginia Universities Awarded $28.5 Million Grant for STEM

Six Virginia universities were selected by the U.S. Department of Education to receive and lead a STEM grant, of $28.5 million from the Invest in Innovation (i3) program to improve K-12 science education (science teaching and student learning) throughout the Commonwealth of Virginia, especially in ... read more ».

CW Optics Begins Trial Of Wound Imaging Technology For Diabetics

CW Optics, Inc., a privately held company specializing in design and development of biophotonic devices, has begun a clinical trial at Richmond’s Chippenham and Johnston-Willis (CJW) Medical Center to investigate the safety and efficacy of WoundImager®, an advanced optical imaging device for ... read more ».

Our Mission

The Virginia Biotechnology Association (VaBIO) is the statewide non-profit organization that promotes the scientific and economic impact of the life sciences industry in the Commonwealth of Virginia. Approximately 200 biotechnology, pharmaceutical and medical device companies are based in Virginia, mainly clustered around universities in Blacksburg, Charlottesville, Richmond, Norfolk and Northern Virginia. According to a recent study by Archstone LLC, the bioscience industry has a profound impact on the state’s economy:

• According to a study in 2006, the bioscience industry supported nearly 80,000 direct and indirect jobs in the Commonwealth.
• The value of the industry’s products and services was approximately $12.6 billion in 2006.
• The biopharmaceutical industry grew by 8.1% between 1996 and 2006.
• The industry paid employees about $1.8 billion in wages in 2006, resulting in $81.6 million in state taxes and $433.3 million in federal taxes.
• Biopharmaceutical employees paid, on average, $4,091 in state taxes, compared to the much more modest $1,501 paid by the average worker.
• In 2008, Virginia’s biomedical researchers conducted nearly 1,900 clinical tests of new medicines, including 678 trials for cancer drugs, 102 tests for heart disease medicines, 232 rare disease treatment trials and 80 tests for HIV/AIDS drugs.